查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2148957

獸用疫苗佐劑市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測

Veterinary Vaccine Adjuvants Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 132 Pages | 商品交期: 2-3個工作天內

價格

獸用疫苗佐劑市場成長要素

全球獸用疫苗佐劑市場預計2025年達到5.2298億美元，2026年達到5.7517億美元，到2034年將達到12.3114億美元。推動該市場成長的因素包括動物保健支出增加、疫苗接種計劃擴大、佐劑研發技術進步以及人們對通用感染疾病的日益關注。2025年，北美將以41.79%的市場佔有率領先。獸用疫苗佐劑能夠增強免疫反應並提高疫苗效力。常用佐劑包括鋁鹽、油性乳劑、皂素、脂質體、奈米顆粒和其他免疫刺激化合物。

市場定義和範圍

獸用疫苗佐劑是添加到動物疫苗中的物質，用於增強免疫反應，提高疫苗的有效性和保護持續時間。佐劑的選擇取決於多種因素，例如動物種類、疫苗抗原、病原體、給藥途徑以及所需的免疫類型。對更安全、更具標靶性的佐劑的研究加速開發用於家畜和伴侶動物的先進疫苗配方。

市場動態

促進因素

新興經濟體對動物健康日益成長的關注

世界各國政府和獸醫組織提高人們對牲畜健康、動物疫苗接種和通用感染疾病預防的認知。新興經濟體疫苗接種計畫的擴展促進有效動物疫苗的使用，並推動對佐劑技術的需求。

通用感染疾病發生率增加

動物與人類之間疾病傳播的日益增多，推動了對預防性獸醫保健需求的成長。疫苗接種在控制家畜和伴侶動物感染疾病、降低傳播風險方面發揮著非常重要的作用，這因而又催生了對先進疫苗佐劑的需求。

趨勢

新型佐劑技術的進展

皂素、脂質體、病毒體、顆粒製劑和其他先進佐劑的研發改變獸用疫苗的開發。現代科技致力於誘導更強效、更特異性的免疫反應，同時減少副作用。預計這些創新將推動市場在2034年之前持續擴張。

阻礙因素

副作用和高毒性

某些佐劑可能產生一些副作用，例如發燒、疼痛、嗜睡、食慾不振和其他不良反應，可能會限制其應用。此外，生產商還需進行額外的安全性測試和上市後監測，這可能導致研發成本增加和監管流程更加複雜。

細分分析

依類型

市場細分包括明礬和鈣鹽、油性乳劑佐劑、脂質體和古菌體、奈米顆粒和微粒以及其他產品。明礬和鈣鹽預計仍將保持領先地位，這得益於其在獸用疫苗領域成熟的應用歷史和廣泛的應用範圍。到2025年，該細分市場將佔據32.4%的市場。由於畜牧疫苗接種和感染疾病預防的日益普及，油性乳劑佐劑預計將強勁成長。

依用途

市場分為研究應用與商業應用兩大領域。由於新型佐劑的持續研發以及政府和製藥公司投資的不斷增加，研究應用領域預計將保持領先地位。2025年研究應用領域市場規模將達到2.663億美元。隨著獸用疫苗生產商擴大使用先進佐劑配方，商業應用領域也預計將擴大。

依給藥途徑

市場涵蓋口服、皮下、肌肉注射及其他給藥途徑。由於肌肉注射具有誘導標靶免疫反應的卓越能力，預計將繼續保持主導地位。雖然到2025年口服給藥市場佔有率將達到26.2%，但其他給藥途徑，包括皮內注射，由於其吸收時間更長、作用持續時間更長，預計將受到更多關注。

依動物類型

市場分為牲畜和伴侶動物兩大類。由於牲畜數量的增加和動物疾病發病率的上升，牲畜市場佔據了主要佔有率。伴侶動物市場預計將呈現強勁成長，這得益於寵物數量的增加、可支配收入的提高以及寵物醫療保健技術的進步。

區域趨勢

北美洲

北美是獸用疫苗佐劑市場的主要驅動力，2025年市場規模達到1.5884億美元。該地區完善的獸醫基礎設施、對通用感染疾病日益成長的認知以及預防性獸醫保健的普及，都支撐著市場需求。美國憑藉其廣泛的獸醫疫苗接種計劃，仍然是主要的需求來源。

歐洲

歐洲佔據第二大市場佔有率，預計強勁的需求將持續。獸醫保健設施的發展、政府支持的免疫接種計劃以及先進動物疫苗的日益普及，都在推動市場成長。

亞太地區

由於醫療基礎設施的擴建以及各國政府對牲畜疫苗接種的日益重視，亞太地區預計將迎來顯著成長。到2025年，日本市場規模將達到1,200萬美元，而中國市場預計在整個預測期內都將保持強勁成長。

拉丁美洲、中東和非洲

在這些地區，由於動物健康意識的提高和牲畜疫苗接種計劃的擴大，市場預計將會成長。對獸醫基礎設施和疾病預防投入的增加，可能為疫苗佐劑生產商創造更多商機。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會

第4章 主要考察

  • 概述：獸用疫苗佐劑技術
  • 新疫苗接種方法概述
  • 動物疫苗的進展
  • 產業重大發展：合併、收購與合作。

第5章 2021-2034年全球獸用疫苗佐劑市場分析、洞察與預測

  • 主要發現與總結
  • 市場分析、洞察與預測：依類型
    • 明礬和鈣鹽
    • 油性乳劑助劑
    • 脂質體和古細菌體
    • 奈米顆粒和微米顆粒
    • 其他
  • 市場分析、洞察與預測：依應用領域分類
    • 調查
    • 商業
  • 市場分析、洞察與預測：依給藥途徑
    • 口服
    • 皮下
    • 肌肉內部
    • 其他
  • 市場分析、洞察與預測：依動物類型分類
    • 家畜
    • 伴侶動物
  • 市場分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美獸用疫苗佐劑市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲獸用疫苗佐劑市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章 亞太地區獸用疫苗佐劑市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章 拉丁美洲獸用疫苗佐劑市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中東和非洲獸用疫苗佐劑市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 主要行業趨勢
  • 全球市場佔有率分析（2025年）
  • 公司簡介
    • Croda International Plc（UK）
    • Zoetis（US）
    • Phibro Animal Health Corporation（US）
    • SEPPIC（France）
    • SPI Pharma（US）
    • Bioveta, as（Czechia）
    • Merck & Co., Inc.（US）
    • Avanti Polar Lipids, Inc.（US）
    • OZ Biosciences FRANCE
    • InvivoGen（US）
    • Other Prominent Players

第12章 戰略建議

Product Code: FBI101155

Growth Factors of veterinary vaccine adjuvants Market

The global veterinary vaccine adjuvants market size was valued at USD 522.98 million in 2025 and is projected to reach USD 575.17 million in 2026 and USD 1,231.14 million by 2034. The market is supported by increasing animal healthcare expenditure, growing vaccination programs, technological advancements in adjuvant development, and rising concerns regarding zoonotic diseases. North America dominated the market with a 41.79% share in 2025. Veterinary vaccine adjuvants enhance immune responses and improve vaccine effectiveness, with commonly used materials including aluminum salts, oil emulsions, saponins, liposomes, nanoparticles, and other immune-stimulating compounds.

Market Definition and Scope

Veterinary vaccine adjuvants are substances incorporated into animal vaccines to strengthen immune responses and improve the effectiveness and duration of protection. Their selection depends on factors such as animal species, vaccine antigen, pathogen, administration route, and required type of immunity. Increasing research into safer and more targeted adjuvants is encouraging the development of advanced formulations for livestock and companion animals.

Market Dynamics

Drivers

Growing Awareness of Animal Health in Emerging Economies

Governments and veterinary organizations are increasing awareness of livestock health, animal vaccination, and zoonotic disease prevention. Expanding vaccination programs in emerging economies are encouraging the use of effective veterinary vaccines and supporting demand for adjuvant technologies.

Growing Incidence of Infectious Zoonotic Diseases

The increasing occurrence of diseases transmitted between animals and humans is strengthening demand for preventive veterinary healthcare. Vaccination plays an important role in controlling infectious diseases in livestock and companion animals while reducing transmission risks, creating opportunities for advanced vaccine adjuvants.

Trends

Novel Adjuvant Technological Advancements

The development of saponins, liposomes, virosomes, particle-based formulations, and other advanced adjuvants is transforming veterinary vaccine development. Modern technologies are focused on generating stronger and more specific immune responses while reducing adverse reactions. Such innovations are expected to support market expansion through 2034.

Restraints

Adverse Effects and High Toxicity

Potential adverse effects associated with certain adjuvants, including fever, soreness, lethargy, anorexia, and other reactions, can restrict adoption. Manufacturers also face additional safety testing and post-marketing monitoring requirements, which can increase development costs and regulatory complexity.

Segmentation Analysis

By Type

The market is segmented into alum and calcium salts, oil emulsion adjuvants, liposomes and archaeosomes, nanoparticles and microparticles, and others. Alum and calcium salts are expected to remain a leading segment, supported by their established use in veterinary vaccines and broad application. The segment is expected to hold a 32.4% share in 2025. Oil emulsion adjuvants are projected to experience strong growth due to increasing livestock vaccination and infectious disease prevention.

By Application

The market is divided into research and commercial use. Research applications are expected to maintain a leading position because of ongoing development of novel adjuvants and increasing investment from governments and pharmaceutical companies. The research application segment is projected to reach USD 266.3 million in 2025. Commercial applications are also expected to expand as veterinary vaccine manufacturers increase the use of advanced adjuvant formulations.

By Route of Administration

The market includes oral, subcutaneous, intramuscular, and others. Intramuscular administration is expected to maintain a dominant position because of its effectiveness in generating targeted immune responses. The oral segment is expected to account for 26.2% in 2025, while other routes, including intradermal administration, are expected to gain attention due to extended absorption and duration of action.

By Type of Animals

The market is categorized into livestock and companion animals. Livestock animals represent a major segment because of the expanding livestock population and rising incidence of animal diseases. Companion animals are expected to witness strong growth as pet ownership increases, disposable income improves, and pet healthcare becomes more advanced.

Regional Insights

North America

North America dominated the veterinary vaccine adjuvants market, reaching USD 158.84 million in 2025. Well-established veterinary healthcare infrastructure, growing awareness of zoonotic diseases, and increasing use of preventive animal healthcare are supporting regional demand. The U.S. remains a major contributor because of extensive veterinary vaccination programs.

Europe

Europe held the second-largest position and is expected to maintain substantial demand. Improving veterinary healthcare facilities, government-supported immunization programs, and increasing adoption of advanced animal vaccines are supporting market development.

Asia Pacific

Asia Pacific is expected to witness significant growth as animal healthcare infrastructure expands and governments increase focus on livestock vaccination. Japan's market is expected to reach USD 12.0 million in 2025, while China is projected to experience strong development during the forecast period.

Latin America and Middle East & Africa

These regions are expected to progress as awareness of animal health increases and livestock vaccination programs expand. Rising investments in veterinary infrastructure and disease prevention can create additional opportunities for vaccine adjuvant manufacturers.

Competitive Landscape

Major companies operating in the veterinary vaccine adjuvants market include Croda International Plc, Zoetis, Phibro Animal Health Corporation, SEPPIC, SPI Pharma, Bioveta, Merck & Co., Avanti Polar Lipids, OZ Biosciences, and InvivoGen. Companies are focusing on acquisitions, partnerships, product development, and novel adjuvant technologies to strengthen their portfolios.

Key Industry Developments

Recent developments include Merck Animal Health's expansion of its veterinary vaccine platform, Zoetis' launch of an expanded porcine vaccine in Europe, and Croda International's acquisition of Avanti Polar Lipids to strengthen its lipid-based drug delivery and vaccine-adjuvant capabilities. Strategic investments and product innovation remain important competitive strategies.

Report Coverage

The veterinary vaccine adjuvants market report covers market size and value for 2025, 2026, and 2034, along with market trends, growth drivers, restraints, segmentation by type, application, route of administration, and animal type. It also examines regional performance, leading companies, technological developments, strategic initiatives, and major industry developments influencing the market.

Conclusion

The veterinary vaccine adjuvants market is positioned for sustained expansion through 2034, supported by rising animal healthcare awareness, increasing zoonotic disease concerns, expanding livestock vaccination, and continued development of advanced adjuvant technologies. Alum and calcium salts remain important because of their established application, while innovative emulsions, liposomes, nanoparticles, and other formulations are creating new opportunities. North America continues to represent the leading regional market, while Asia Pacific offers significant potential as veterinary infrastructure and vaccination programs expand.

By Type

  • Alum and Calcium Salts
  • Oil Emulsion Adjuvants
  • Liposomes and Archaeosomes
  • Nanoparticles and Microparticles
  • Others

SEGMENTATION By Application

  • Research Application
  • Commercial Application

By Route of Administration

  • Oral
  • Subcutaneous
  • Intramuscular
  • Others

By Animal Type

  • Livestock
  • Companion Animals

By Geography

  • North America (the U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia Pacific (India, Japan, Australia, Southeast Asia, China, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • The Middle East and Africa (GCC, South Africa, Rest of MEA)

Table of Content

1. Introduction

  • 1.1. Market Scope
  • 1.2. Market Segmentation
  • 1.3. Market Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Snapshot: Veterinary Vaccines Adjuvants Technology
  • 4.2. Overview of New Vaccines Delivery Modes
  • 4.3. Advancements in Animal Health Vaccines
  • 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships

5. Global Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Alum and Calcium Salts
    • 5.2.2. Oil Emulsion Adjuvants
    • 5.2.3. Liposomes and Archaeosomes
    • 5.2.4. Nanoparticles and Microparticles
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Research
    • 5.3.2. Commercial
  • 5.4. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.4.1. Oral
    • 5.4.2. Subcutaneous
    • 5.4.3. Intramuscular
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Animal Type
    • 5.5.1. Livestock Animals
    • 5.5.2. Companion Animals
  • 5.6. Market Analysis, Insights and Forecast - By Geography
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Alum and Calcium Salts
    • 6.2.2. Oil Emulsion Adjuvants
    • 6.2.3. Liposomes and Archaeosomes
    • 6.2.4. Nanoparticles and Microparticles
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Research
    • 6.3.2. Commercial
  • 6.4. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.4.1. Oral
    • 6.4.2. Subcutaneous
    • 6.4.3. Intramuscular
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Animal Type
    • 6.5.1. Livestock Animals
    • 6.5.2. Companion Animals
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Alum and Calcium Salts
    • 7.2.2. Oil Emulsion Adjuvants
    • 7.2.3. Liposomes and Archaeosomes
    • 7.2.4. Nanoparticles and Microparticles
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Research
    • 7.3.2. Commercial
  • 7.4. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.4.1. Oral
    • 7.4.2. Subcutaneous
    • 7.4.3. Intramuscular
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Animal Type
    • 7.5.1. Livestock Animals
    • 7.5.2. Companion Animals
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Alum and Calcium Salts
    • 8.2.2. Oil Emulsion Adjuvants
    • 8.2.3. Liposomes and Archaeosomes
    • 8.2.4. Nanoparticles and Microparticles
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Research
    • 8.3.2. Commercial
  • 8.4. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.4.1. Oral
    • 8.4.2. Subcutaneous
    • 8.4.3. Intramuscular
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Animal Type
    • 8.5.1. Livestock Animals
    • 8.5.2. Companion Animals
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Alum and Calcium Salts
    • 9.2.2. Oil Emulsion Adjuvants
    • 9.2.3. Liposomes and Archaeosomes
    • 9.2.4. Nanoparticles and Microparticles
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Research
    • 9.3.2. Commercial
  • 9.4. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.4.1. Oral
    • 9.4.2. Subcutaneous
    • 9.4.3. Intramuscular
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Animal Type
    • 9.5.1. Livestock Animals
    • 9.5.2. Companion Animals
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Veterinary Vaccine Adjuvants Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Alum and Calcium Salts
    • 10.2.2. Oil Emulsion Adjuvants
    • 10.2.3. Liposomes and Archaeosomes
    • 10.2.4. Nanoparticles and Microparticles
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Research
    • 10.3.2. Commercial
  • 10.4. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.4.1. Oral
    • 10.4.2. Subcutaneous
    • 10.4.3. Intramuscular
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Animal Type
    • 10.5.1. Livestock Animals
    • 10.5.2. Companion Animals
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2025)
  • 11.3. Company Profiles
    • 11.3.1. Croda International Plc (UK)
      • 11.3.1.1. Overview,
      • 11.3.1.2. Type Types & Services,
      • 11.3.1.3. SWOT Analysis,
      • 11.3.1.4. Recent Developments,
      • 11.3.1.5. Strategies,
      • 11.3.1.6. Financials (Based on Availability)
    • 11.3.2. Zoetis (U.S.)
      • 11.3.2.1. Overview,
      • 11.3.2.2. Type Types & Services,
      • 11.3.2.3. SWOT Analysis,
      • 11.3.2.4. Recent Developments,
      • 11.3.2.5. Strategies,
      • 11.3.2.6. Financials (Based on Availability)
    • 11.3.3. Phibro Animal Health Corporation (U.S)
      • 11.3.3.1. Overview,
      • 11.3.3.2. Type Types & Services,
      • 11.3.3.3. SWOT Analysis,
      • 11.3.3.4. Recent Developments,
      • 11.3.3.5. Strategies,
      • 11.3.3.6. Financials (Based on Availability)
    • 11.3.4. SEPPIC (France)
      • 11.3.4.1. Overview,
      • 11.3.4.2. Type Types & Services,
      • 11.3.4.3. SWOT Analysis,
      • 11.3.4.4. Recent Developments,
      • 11.3.4.5. Strategies,
      • 11.3.4.6. Financials (Based on Availability)
    • 11.3.5. SPI Pharma (U.S)
      • 11.3.5.1. Overview,
      • 11.3.5.2. Type Types & Services,
      • 11.3.5.3. SWOT Analysis,
      • 11.3.5.4. Recent Developments,
      • 11.3.5.5. Strategies,
      • 11.3.5.6. Financials (Based on Availability)
    • 11.3.6. Bioveta, a.s. (Czechia)
      • 11.3.6.1. Overview,
      • 11.3.6.2. Type Types & Services,
      • 11.3.6.3. SWOT Analysis,
      • 11.3.6.4. Recent Developments,
      • 11.3.6.5. Strategies,
      • 11.3.6.6. Financials (Based on Availability)
    • 11.3.7. Merck & Co., Inc. (U.S)
      • 11.3.7.1. Overview,
      • 11.3.7.2. Type Types & Services,
      • 11.3.7.3. SWOT Analysis,
      • 11.3.7.4. Recent Developments,
      • 11.3.7.5. Strategies,
      • 11.3.7.6. Financials (Based on Availability)
    • 11.3.8. Avanti Polar Lipids, Inc. (U.S)
      • 11.3.8.1. Overview,
      • 11.3.8.2. Type Types & Services,
      • 11.3.8.3. SWOT Analysis,
      • 11.3.8.4. Recent Developments,
      • 11.3.8.5. Strategies,
      • 11.3.8.6. Financials (Based on Availability)
    • 11.3.9. OZ Biosciences FRANCE
      • 11.3.9.1. Overview,
      • 11.3.9.2. Type Types & Services,
      • 11.3.9.3. SWOT Analysis,
      • 11.3.9.4. Recent Developments,
      • 11.3.9.5. Strategies,
      • 11.3.9.6. Financials (Based on Availability)
    • 11.3.10. InvivoGen (U.S)
      • 11.3.10.1. Overview,
      • 11.3.10.2. Type Types & Services,
      • 11.3.10.3. SWOT Analysis,
      • 11.3.10.4. Recent Developments,
      • 11.3.10.5. Strategies,
      • 11.3.10.6. Financials (Based on Availability)
    • 11.3.11. Other Prominent Players
      • 11.3.11.1. Overview,
      • 11.3.11.2. Type Types & Services,
      • 11.3.11.3. SWOT Analysis,
      • 11.3.11.4. Recent Developments,
      • 11.3.11.5. Strategies,
      • 11.3.11.6. Financials (Based on Availability)

12. Strategic Recommendations

List of Tables

  • Table 1: Global Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 2: Global Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
  • Table 3: Global Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034
  • Table 4: Global Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Animal Type, 2021-2034
  • Table 5: Global Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
  • Table 6: North America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 7: North America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
  • Table 8: North America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034
  • Table 9: North America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Animal Type, 2021-2034
  • Table 10: North America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
  • Table 11: Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 12: Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
  • Table 13: Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034
  • Table 14: Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Animal Type, 2021-2034
  • Table 15: Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 17: Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
  • Table 18: Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034
  • Table 19: Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Animal Type, 2021-2034
  • Table 20: Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 22: Latin America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
  • Table 23: Latin America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034
  • Table 24: Latin America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Animal Type, 2021-2034
  • Table 25: Latin America Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 27: Middle East & Africa Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Application, 2021-2034
  • Table 28: Middle East & Africa Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Route of Administration, 2021-2034
  • Table 29: Middle East & Africa Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, by Animal Type, 2021-2034
  • Table 30: Middle East & Africa Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Veterinary Vaccine Adjuvants Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034
  • Figure 2: Global Veterinary Vaccine Adjuvants Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Alum and Calcium Salts, 2021-2034
  • Figure 4: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Oil Emulsion Adjuvants, 2021-2034
  • Figure 5: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Liposomes and Archaeosomes, 2021-2034
  • Figure 6: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Nanoparticles and Microparticles, 2021-2034
  • Figure 7: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Others, 2021-2034
  • Figure 8: Global Veterinary Vaccine Adjuvants Market Value Share (%), by Application, 2025 & 2034
  • Figure 9: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Research, 2021-2034
  • Figure 10: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Commercial 2021-2034
  • Figure 11: Global Veterinary Vaccine Adjuvants Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 12: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Oral, 2021-2034
  • Figure 13: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Subcutaneous, 2021-2034
  • Figure 14: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Intramuscular, 2021-2034
  • Figure 15: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Others 2021-2034
  • Figure 16: Global Veterinary Vaccine Adjuvants Market Value Share (%), by Animal Type, 2025 & 2034
  • Figure 17: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Livestock Animals, 2021-2034
  • Figure 18: Global Veterinary Vaccine Adjuvants Market Forecast (US$ Mn), by Companion Animals, 2021-2034
  • Figure 19: Global Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Region, 2025 & 2034
  • Figure 20: North America Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Type, 2025 & 2034
  • Figure 21: North America Veterinary Vaccine Adjuvants Market Value Share (%), by Type, 2025
  • Figure 22: North America Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Application, 2025 & 2034
  • Figure 23: North America Veterinary Vaccine Adjuvants Market Value Share (%), by Application, 2025
  • Figure 24: North America Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Route of Administration, 2025 & 2034
  • Figure 25: North America Veterinary Vaccine Adjuvants Market Value Share (%), by Route of Administration, 2025
  • Figure 26: North America Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Animal Type, 2025 & 2034
  • Figure 27: North America Veterinary Vaccine Adjuvants Market Value Share (%), by Animal Type, 2025
  • Figure 28: North America Veterinary Vaccine Adjuvants Market Value (US$ Mn), By Country, 2025 & 2034
  • Figure 29: North America Veterinary Vaccine Adjuvants Market Value Share (%), By Country, 2025
  • Figure 30: Europe Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Type, 2025 & 2034
  • Figure 31: Europe Veterinary Vaccine Adjuvants Market Value Share (%), by Type, 2025
  • Figure 32: Europe Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Application, 2025 & 2034
  • Figure 33: Europe Veterinary Vaccine Adjuvants Market Value Share (%), by Application, 2025
  • Figure 34: Europe Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Route of Administration, 2025 & 2034
  • Figure 35: Europe Veterinary Vaccine Adjuvants Market Value Share (%), by Route of Administration, 2025
  • Figure 36: Europe Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Animal Type, 2025 & 2034
  • Figure 37: Europe Veterinary Vaccine Adjuvants Market Value Share (%), by Animal Type, 2025
  • Figure 38: Europe Veterinary Vaccine Adjuvants Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 39: Europe Veterinary Vaccine Adjuvants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 40: Asia Pacific Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Type, 2025 & 2034
  • Figure 41: Asia Pacific Veterinary Vaccine Adjuvants Market Value Share (%), by Type, 2025
  • Figure 42: Asia Pacific Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Application, 2025 & 2034
  • Figure 43: Asia Pacific Veterinary Vaccine Adjuvants Market Value Share (%), by Application, 2025
  • Figure 44: Asia Pacific Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Route of Administration, 2025 & 2034
  • Figure 45: Asia Pacific Veterinary Vaccine Adjuvants Market Value Share (%), by Route of Administration, 2025
  • Figure 46: Asia Pacific Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Animal Type, 2025 & 2034
  • Figure 47: Asia Pacific Veterinary Vaccine Adjuvants Market Value Share (%), by Animal Type, 2025
  • Figure 48: Asia Pacific Veterinary Vaccine Adjuvants Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 49: Asia Pacific Veterinary Vaccine Adjuvants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 50: Latin America Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Type, 2025 & 2034
  • Figure 51: Latin America Veterinary Vaccine Adjuvants Market Value Share (%), by Type, 2025
  • Figure 52: Latin America Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Application, 2025 & 2034
  • Figure 53: Latin America Veterinary Vaccine Adjuvants Market Value Share (%), by Application, 2025
  • Figure 54: Latin America Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Route of Administration, 2025 & 2034
  • Figure 55: Latin America Veterinary Vaccine Adjuvants Market Value Share (%), by Route of Administration, 2025
  • Figure 56: Latin America Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Animal Type, 2025 & 2034
  • Figure 57: Latin America Veterinary Vaccine Adjuvants Market Value Share (%), by Animal Type, 2025
  • Figure 58: Latin America Veterinary Vaccine Adjuvants Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 59: Latin America Veterinary Vaccine Adjuvants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 60: Middle East & Africa Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Type, 2025 & 2034
  • Figure 61: Middle East & Africa Veterinary Vaccine Adjuvants Market Value Share (%), by Type, 2025
  • Figure 62: Middle East & Africa Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa Veterinary Vaccine Adjuvants Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Route of Administration, 2025 & 2034
  • Figure 65: Middle East & Africa Veterinary Vaccine Adjuvants Market Value Share (%), by Route of Administration, 2025
  • Figure 66: Middle East & Africa Veterinary Vaccine Adjuvants Market Value (US$ Mn), by Animal Type, 2025 & 2034
  • Figure 67: Middle East & Africa Veterinary Vaccine Adjuvants Market Value Share (%), by Animal Type, 2025
  • Figure 68: Middle East & Africa Veterinary Vaccine Adjuvants Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 69: Middle East & Africa Veterinary Vaccine Adjuvants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 70: Global Veterinary Vaccine Adjuvants Market Share (%), By Company, 2025